MitrAssist
MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.
Based based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), MitrAssist works in biotechnology, health diagnostics, pharmaceutical, founded in 2009.
Its activity falls under biotechnology, health diagnostics, pharmaceutical; the profile below is assembled from public directory data.
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) is where the company is located.
Its current recorded stage is Series_C.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $181M.
| Sector | Biotechnology, Health Diagnostics, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2009 |
| Employees | c_00001_00010 |
| Stage | series_c |
| Total funding | $181,000,000 |
Website: mitrassist.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account